Genetic Testing Company 23andMe Going Public At $3.5 Billion Valuation, Focus On More Therapeutics
While personal genetic testing as entertainment slowed as a revenue source in recent years, 23andMe has doubled down on its therapeutic programs.
Yes, It Is Worth Making A Federal Case Over Angelina Jolie’s Boobs
Angelina Jolie took action to address her cancer risk. If the Supreme Court gets its act together, more women can follow her example.
Labor and Employment Federal Litigation Trends 2026
Drawing on more than a decade of data, the report equips law firms and corporate legal teams with actionable insights to better assess risk, refine strategy, and anticipate outcomes in today’s evolving workplace disputes.